Related Experiment Video
Updated: Jul 17, 2025

Minimal Erythema Dose MED Testing
Published on: May 28, 2013
Delayed Recurrent Erythema Nodosum Following COVID-19 Vaccine: A Case Report
Nada Alghamdi1, Rahmah M Alamrie2, Anmar Y Alshafie1
1Department of Dermatology, King Fahad University Hospital, Khobar, SAU.
Abstract:
Erythema nodosum (EN) is a skin lesion that presents due to an inflammation of the subcutaneous fat, which is manifested clinically as a sudden onset of tender erythematous lesions. These lesions are typically localized to the pretibial surface. The cause of EN is mainly idiopathic, other causes are drugs, infections, autoimmune diseases, and inflammatory bowel disease. As vaccines are rarely known to cause EN, we are reporting a case of a 19-year-old female with a delayed recurrent reaction following the second dose of the COVID-19 vaccine.
More Related Videos
10:27Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
08:04Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Myocarditis III: Medical Management
Allergic Drug Reactions
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis IV: Nursing Management
Cross-reactivity